Cabergoline and quinagolide therapy for prolactinomas.
Webster
J
J
Northern General Hospital, Sheffield, UK.
D000634:Aminoquinolines / Q000627:therapeutic use*; D000077465:Cabergoline; D018592:Cross-Over Studies; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D015175:Prolactinoma / Q000188:drug therapy*; D012107:Research Design; D016896:Treatment Outcome
D000634:Aminoquinolines; D018491:Dopamine Agonists; D004873:Ergolines; C046650:quinagolide; D000077465:Cabergoline